Ignite Creation Date:
2025-12-24 @ 7:19 PM
Ignite Modification Date:
2026-02-18 @ 12:56 AM
Study NCT ID:
NCT03627403
Status:
TERMINATED
Last Update Posted:
2025-06-19
First Post:
2018-08-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Selinexor in Myelofibrosis Refractory or Intolerant to JAK1/2 Inhibitors
Sponsor:
University of Utah
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-10
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-03-05
Completion Date Type:
ACTUAL
First Submit Date:
2018-08-07
First Submit QC Date:
None
Study First Post Date:
2018-08-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-08-16
Results First Submit QC Date:
None
Results First Post Date:
2024-10-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-11
Last Update Post Date:
2025-06-19
Last Update Post Date Type:
ACTUAL